Showing results (111-120 of 431) with videos related to
Sort By:
Pageof 44
Lupus|February 22, 2014
Drug-induced lupus: Including anti-tumour necrosis factor and interferon inducedS Araújo-Fernández, M Ahijón-Lana, D A IsenbergClinical and Experimental Immunology|July 1, 1987
Defective degradation of bacterial DNA by phagocytes from patients with systemic and discoid lupus erythematosusP J Roberts, D A Isenberg, A W SegalAnnals of the Rheumatic Diseases|October 1, 1987
A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessmentJ C Edwards, M L Snaith, D A IsenbergThe Journal of Rheumatology|February 1, 1994
The tissue specific elevation in synthesis of the 90 kDa heat shock protein precedes the onset of disease in lupus prone MRL/lpr miceG B Faulds, D A Isenberg, D S LatchmanAnnals of the Rheumatic Diseases|September 27, 2000
Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective studyT Stoll, N Sutcliffe, R Klaghofer, et al.Journal of Autoimmunity|January 5, 2002
Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90B J Ripley, D A Isenberg, D S LatchmanThe Journal of Rheumatology|October 1, 1984
Elastase activity in serum and synovial fluid of patients with connective tissue disordersL A Cooke, F C Hay, D A IsenbergBritish Journal of Rheumatology|February 4, 1998
beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?M Inanç, E L Radway-Bright, D A IsenbergLupus|January 1, 1997
Elevated soluble fas production in SLE correlates with HLA status not with disease activityL M Rose, D S Latchman, D A IsenbergAnnals of the Rheumatic Diseases|August 1, 1982
Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosusD A Isenberg, W J Morrow, M L SnaithPageof 44